Serum Levels of Interleukin-2 and Interleukin-6 among Helicobacter Pylori Positive Patients in Relation to Prognosis of Gastro-duodenal Disease
DOI:
https://doi.org/10.37506/ijfmt.v16i2.17970Keywords:
: Gastritis; Gastric cancer; Helicobacter pylori; IL-6, IL-2; Peptic ulcer.Abstract
Background: Helicobacter pylori is the most widespread pathogenic associated with gastro-duodenal
Disease. Interleukin 2 and interleukin 6 are the main cytokines involved in host immune response to
H.pylori infection. The aim of the present study are to assess the serum level of IL-6 and IL–2 in
H.pylori infected patients and to study their association with gastric endoscopy findings. Methods:
One hundred and seven suspected patients and 19 healthy were recruited. The confirmed positivity of
H.pylori detection was based on a rapid urease test (R.U.T) and stool antigen test. Serum concentrations
of IL-2 and IL-6 were measuring by ELISA. Results: Seventy-five (70%) patients were positive for
H.pylori. Both interleukins were found at higher levels in patients than in healthy (p- value <0.05).
Interestingly, the level of IL-2 was lower in patients infected with H.pylori (43.40 pg/ml) than those
who were not infected (85.2 pg/ml), while the level of IL-6 was higher in patients infected with H.pylori
(117 pg/ml) than those not infected (40 pg/ml), p-value <0.05. Furthermore, the increasing levels of
both interleukins were correlated with disease progress.
Downloads
Published
Issue
Section
License
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions